Risk factors predicting recurrence in patients operated on for intracranial meningioma. A multivariate analysis
- PMID: 10526073
- DOI: 10.1007/s007010050398
Risk factors predicting recurrence in patients operated on for intracranial meningioma. A multivariate analysis
Abstract
The authors undertook a follow-up study of 286 patients who underwent surgical treatment for intracranial meningioma between 1973 and 1994, in order to analyse clinical, radiological, topographic, histopathological and therapeutic factors significantly influencing tumour recurrence. All patients were followed by using either computed tomography (CT) or magnetic resonance from 3 months to 17 years since first surgery (mean follow-up: 4.1 years). Forty-four (15.4%) recurrences were detected during this time period. Overall recurrence rates were 14%, 37% and 61% at 5, 10 and 15 years, respectively. Factors significantly associated with tumour relapse in bivariate analysis were: tumour location at petroclival and parasagittal (middle third) regions, incomplete surgical resection (assessed by Simpson's classification), atypical and malignant histological types (WHO classification), presence of nucleolar prominence, presence of more than 2 mitosis per 10 high-power fields, and heterogeneous tumour contrast enhancement on the CT scan. The multivariate analysis using the Cox's proportional hazards model identified the following risk factors for recurrence: incomplete surgical resection (Relative risk: 2.2; 95% Confidence interval: 1.33-3.64), non conventional histological type (RR: 2.13; 95%CI: 1-4.53), heterogeneous contrast enhancement on the CT scan (RR: 2.25; 95%CI: 1.1-4.72) and presence of more than 2 mitosis per 10 high-power fields (RR: 2.28; 95%CI: 0.99-5.27). Patients without any of these features showed low recurrence rates (4% and 18% at 5 and 10 years), and thus, they need less clinical and radiological controls through the follow-up than patients with some of these risk factors.
Similar articles
-
Clear cell meningioma: clinical features, CT, and MR imaging findings in 23 patients.J Comput Assist Tomogr. 2014 Mar-Apr;38(2):200-8. doi: 10.1097/RCT.0000000000000018. J Comput Assist Tomogr. 2014. PMID: 24625613
-
World Health Organization Grade II Meningioma: A 10-Year Retrospective Study for Recurrence and Prognostic Factor Assessment.World Neurosurg. 2016 May;89:180-6. doi: 10.1016/j.wneu.2016.01.055. Epub 2016 Feb 2. World Neurosurg. 2016. PMID: 26850975
-
Brain oedema in patients with intracranial meningioma. Correlation between clinical, radiological, and histological factors and the presence and intensity of oedema.Acta Neurochir (Wien). 1996;138(5):485-93; discussion 493-4. doi: 10.1007/BF01411166. Acta Neurochir (Wien). 1996. PMID: 8800322
-
Surgical management of petroclival meningiomas: defining resection goals based on risk of neurological morbidity and tumor recurrence rates in 137 patients.Neurosurgery. 2005 Mar;56(3):546-59; discussion 546-59. doi: 10.1227/01.neu.0000153906.12640.62. Neurosurgery. 2005. PMID: 15730581 Review.
-
Meningiomas in children and adolescents: a meta-analysis of individual patient data.Lancet Oncol. 2011 Dec;12(13):1229-39. doi: 10.1016/S1470-2045(11)70275-3. Epub 2011 Nov 15. Lancet Oncol. 2011. PMID: 22094004 Review.
Cited by
-
Early recurrences in histologically benign/grade I meningiomas are associated with large tumors and coexistence of monosomy 14 and del(1p36) in the ancestral tumor cell clone.Neuro Oncol. 2007 Oct;9(4):438-46. doi: 10.1215/15228517-2007-026. Epub 2007 Aug 17. Neuro Oncol. 2007. PMID: 17704362 Free PMC article.
-
Role of MR Morphology and Diffusion-Weighted Imaging in the Evaluation of Meningiomas: Radio-Pathologic Correlation.JNMA J Nepal Med Assoc. 2019 Jan-Feb;57(215):37-44. doi: 10.31729/jnma.3968. JNMA J Nepal Med Assoc. 2019. PMID: 31080244 Free PMC article.
-
Differentiation of benign angiomatous and microcystic meningiomas with extensive peritumoral edema from high grade meningiomas with aid of diffusion weighted MRI.Biomed Res Int. 2014;2014:650939. doi: 10.1155/2014/650939. Epub 2014 Nov 16. Biomed Res Int. 2014. PMID: 25478572 Free PMC article.
-
Surgical Outcome of Treating Grades II and III Meningiomas: A Report of 32 Cases.Neurosci J. 2013;2013:706481. doi: 10.1155/2013/706481. Epub 2012 Nov 5. Neurosci J. 2013. PMID: 26317097 Free PMC article.
-
Opportunities for clinical research in meningioma.J Neurooncol. 2010 Sep;99(3):417-22. doi: 10.1007/s11060-010-0375-6. Epub 2010 Sep 11. J Neurooncol. 2010. PMID: 20835750 Review.
MeSH terms
LinkOut - more resources
Full Text Sources